Forte Biosciences, Inc.
FBRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $267 | $152 | $88 | $145 |
| - Cash | $93 | $106 | $46 | $22 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $173 | $46 | $43 | $123 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$18 | -$12 | -$16 | -$7 |
| % Margin | – | – | – | – |
| Net Income | -$18 | -$11 | -$16 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.99 | -0.96 | -1.37 | -1.12 |
| % Growth | -3.1% | 29.9% | -22.3% | – |
| Operating Cash Flow | -$14 | -$10 | -$10 | -$10 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$14 | -$10 | -$10 | -$10 |